Lipid II as a target for antibiotics (original) (raw)

• Weigel, L. M. et al. Genetic analysis of a high-level vancomycin-resistant isolate of Staphylococcus aureus. Science 302, 1569–1571 (2003).
  Article CAS PubMed Google Scholar
• Harz, H., Burgdorf, K. & Holtje, J.-V. Isolation and separation of the glycan strands from murein of Escherichia coli by reversed-phase high-performance liquid chromatography. Anal. Biochem. 190, 120–128 (1990).
  Article CAS PubMed Google Scholar
• Kramer, N. E. et al. Resistance of Gram-positive bacteria to nisin is not determined by Lipid II levels. FEMS Microbiol. Lett. 239, 157–161 (2004).
  Article CAS PubMed Google Scholar
• Stone, K. J. & Strominger, J. L. Binding of bacitracin to cells and protoplasts of Micrococcus lysodeikticus. J. Biol. Chem. 249, 1823–1827 (1973).
  Google Scholar
• Labischinski, H., Goodell, E. W., Goodell, A. & Hochberg, M. L. Direct proof of a 'more than single-layered' peptidoglycan architecture of Escherichia coli. J. Bacteriol. 136, 723–729 (1991).
  Google Scholar
• McCloskey, M. A. & Troy, F. A. Paramagnetic isoprenoid carrier lipids. 2. Dispersion and dynamics in lipid membranes. Biochemistry 19, 2061–2066 (1980).
  Article CAS PubMed Google Scholar
• Chatterjee, C., Paul, M., Xie, L. L. & van der Donk, W. A. Biosynthesis and mode of action of lantibiotics. Chem. Rev. 105, 633–683 (2005). An in-depth review of aspects of the synthesis and mode of action of lantibiotics.
  Article CAS PubMed Google Scholar
• Ekkelenkamp, M. B. et al. Isolation and structural characterization of epilancin 15X, a novel lantibiotic from a clinical strain of Staphylococcus epidermidis. FEBS Lett. 579, 1917–1922 (2005).
  Article CAS PubMed Google Scholar
• Rogers, L. A. The inhibiting effect of Streptococcus lactis on Lactobacillus bulgaricus. J. Bacteriol. 16, 321–325 (1928).
  CAS PubMed PubMed Central Google Scholar
• Rogers, L. A. & Whittier, E. O. Limiting factors in the lactic fermentation. J. Bacteriol. 16, 211–229 (1928).
  CAS PubMed PubMed Central Google Scholar
• Delves-Broughton, J., Blackburn, P., Evans, R. J. & Hugenholtz, J. Applications of the bacteriocin, nisin. Antonie Van Leeuwenhoek 69, 193–202 (1996).
  Article CAS PubMed Google Scholar
• Linnett, P. E. & Strominger, J. L. Additional antibiotic inhibitors of peptidoglycan synthesis. J. Biol. Chem. 4, 231–236 (1973). First article describing the binding of nisin to Lipid II.
  CAS Google Scholar
• Reisinger, P., Seidel, H., Tschesche, H. & Hammes, W. P. The effect of nisin on murein synthesis. Arch. Microbiol. 127, 187–193 (1980).
  Article CAS PubMed Google Scholar
• Sahl, H.-G. in Nisin and Novel Lantibiotics (eds. Jung, G. & Sahl, H.-G.) 347–358 (ESCOM Science, Leiden, 1991).
  Google Scholar
• Ruhr, E. & Sahl, H. G. Mode of action of the peptide antibiotic nisin and influence on the membrane potential of whole cells and on cytoplasmic and artificial membrane vesicles. Antimicrob. Agents Chemother. 27, 841–845 (1985).
  Article CAS PubMed PubMed Central Google Scholar
• Garcera, M. J., Elferink, M. G., Driessen, A. J. & Konings, W. N. In vitro pore-forming activity of the lantibiotic nisin. Role of protonmotive force and lipid composition. Eur. J. Biochem. 212, 417–422 (1993).
  Article CAS PubMed Google Scholar
• Breukink, E. et al. The C-terminal region of nisin is responsible for the initial interaction of nisin with the target membrane. Biochemistry 36, 6968–6976 (1997).
  Article CAS PubMed Google Scholar
• Breukink, E., Ganz, P., de Kruijff, B. & Seelig, J. Binding of nisin Z to bilayer vesicles as determined with isothermal titration calorimetry. Biochemistry 39, 10247–10254 (2000).
  Article CAS PubMed Google Scholar
• Martin, I., Ruysschaert, J. M., Sanders, D. & Giffard, C. J. Interaction of the lantibiotic nisin with membranes revealed by fluorescence quenching of an introduced tryptophan. Eur. J. Biochem. 239, 156–164 (1996).
  Article CAS PubMed Google Scholar
• Brotz, H. et al. Role of lipid-bound peptidoglycan precursors in the formation of pores by nisin, epidermin and other lantibiotics. Mol. Microbiol. 30, 317–327 (1998).
  Article CAS PubMed Google Scholar
• Breukink, E. et al. Use of the cell wall precursor lipid II by a pore-forming peptide antibiotic. Science 286, 2361–2364 (1999). The authors describe how nisin exploits Lipid II in pore formation.
  Article CAS PubMed Google Scholar
• Matsuzaki, K., Murase, O., Fujii, N. & Miyajima, K. Translocation of a channel-forming antimicrobial peptide, magainin 2, across lipid bilayers by forming a pore. Biochemistry 34, 6521–6526 (1995).
  Article CAS PubMed Google Scholar
• van Kraaij, C. et al. Pore formation by nisin involves translocation of its C-terminal part across the membrane. Biochemistry 37, 16033–16040 (1998).
  Article CAS PubMed Google Scholar
• Brogden, K. A. Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria? Nature Rev. Microbiol. 3, 238–250 (2005).
  Article CAS Google Scholar
• Wiedemann, I. et al. Specific binding of nisin to the peptidoglycan precursor lipid II combines pore formation and inhibition of cell wall biosynthesis for potent antibiotic activity. J. Biol. Chem. 276, 1772–1779 (2001).
  Article CAS PubMed Google Scholar
• Breukink, E. et al. The orientation of nisin in membranes. Biochemistry 37, 8153–8162 (1998).
  Article CAS PubMed Google Scholar
• Sahl, H. G., Kordel, M. & Benz, R. Voltage-dependent depolarization of bacterial membranes and artificial lipid bilayers by the peptide antibiotic nisin. Arch. Microbiol. 149, 120–124 (1987).
  Article CAS PubMed Google Scholar
• van Heusden, H. E., de Kruijff, B. & Breukink, E. Lipid II induces a transmembrane orientation of the pore forming peptide lantibiotic nisin. Biochemistry 41, 12171–12178 (2002).
  Article CAS PubMed Google Scholar
• Wiedemann, I., Benz, R. & Sahl, H.-G. Lipid II-mediated pore formation by the peptide antibiotic nisin — a black lipid membrane study. J. Bacteriol. 186, 3259–3261 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Breukink, E. et al. Lipid II is an intrinsic component of the pore induced by nisin in bacterial membranes. J. Biol. Chem. 278, 19898–19903 (2003).
  Article CAS Google Scholar
• Bonev, B. B., Breukink, E., Swiezewska, E., de Kruijff, B. & Watts, A. Targeting extracellular pyrophosphates underpins the high selectivity of nisin. FASEB J. 18, 1862–1869 (2004).
  Article CAS PubMed Google Scholar
• Hasper, H. E., de Kruijff, B. & Breukink, E. Assembly and stability of nisin–Lipid II pores. Biochemistry 43, 11567–11575 (2004).
  Article CAS PubMed Google Scholar
• Hsu, S. T. D. et al. The nisin–lipid II complex reveals a pyrophosphate cage that provides a blueprint for novel antibiotics. Nature Struct. Mol. Biol. 11, 963–967 (2004).
  Article CAS Google Scholar
• Chan, W. C. et al. Structure–activity relationships in the peptide antibiotic nisin: antibacterial activity of fragments of nisin. FEBS Lett. 390, 129–132 (1996).
  Article CAS PubMed Google Scholar
• Arthur, M. & Courvalin, P. Genetics and mechanisms of glycopeptide resistance in Enterococci. Antimicrob. Agents Chemother. 37, 1563–1571 (1993).
  Article CAS PubMed PubMed Central Google Scholar
• Brotz, H., Bierbaum, G., Leopold, K., Reynolds, P. E. & Sahl, H.-G. The lantibiotic mersacidin inhibits peptidoglycan synthesis by targeting Lipid II. Antimicrob. Agents Chemother. 42, 154–160 (1998).
  Article CAS PubMed PubMed Central Google Scholar
• Hsu, S. T. D. et al. NMR study of mersacidin and lipid II interaction in dodecylphosphocholine micelles — conformational changes are a key to antimicrobial activity. J. Biol. Chem. 278, 13110–13117 (2003).
  Article CAS PubMed Google Scholar
• Martin, N. I. et al. Structural characterization of lacticin 3147, a two-peptide lantibiotic with synergistic activity. Biochemistry 43, 3049–3056 (2004).
  Article CAS PubMed Google Scholar
• Cavalleri, B., Pagani, H., Volpe, G., Selva, E. & Parenti, F. A-16686, a new antibiotic from Actinoplanes. I. Fermen-tation, isolation and preliminary physico-chemical characteristics. J. Antibiot. (Tokyo) 37, 309–317 (1984).
  Article CAS Google Scholar
• McCafferty, D. G. et al. Chemistry and biology of the ramoplanin family of peptide antibiotics. Biopolymers 66, 261–284 (2002).
  Article CAS PubMed Google Scholar
• Walker, S. et al. Chemistry and biology of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity. Chem. Rev. 105, 449–476 (2005). An in-depth review that describes aspects of the synthesis and mode of action of ramoplanin.
  Article CAS PubMed Google Scholar
• Cudic, P. et al. Complexation of peptidoglycan intermediates by the lipoglycodepsipeptide antibiotic ramoplanin: minimal structural requirements for intermolecular complexation and fibril formation. Proc. Natl Acad. Sci. USA 99, 7384–7389 (2002).
  Article CAS PubMed Google Scholar
• Rew, Y., Shin, D., Hwang, I. & Boger, D. L. Total synthesis and examination of three key analogues of ramoplanin: a lipoglycodepsipeptide with potent antibiotic activity. J. Am. Chem. Soc. 126, 1041–1043 (2004).
  Article CAS PubMed Google Scholar
• Jiang, W., Wanner, J., Lee, R. J., Bounaud, P. Y. & Boger, D. L. Total synthesis of the ramoplanin A2 and ramoplanose aglycon. J. Am. Chem. Soc. 125, 1877–1887 (2003).
  Article CAS PubMed Google Scholar
• Helm, J. S., Chen, L. & Walker, S. Rethinking ramoplanin: the role of substrate binding in inhibition of peptidoglycan biosynthesis. J. Am. Chem. Soc. 124, 13970–13971 (2002).
  Article CAS PubMed Google Scholar
• Ciabatti, R., Maffioli, S. I., Romano, G., Candiani, G. & Panzone, G. A process for the production of ramoplanin-like amide derivatives. Chem. Abstr. 139, 261566 (2003).
  Google Scholar
• Chen, L. et al. Dissecting ramoplanin: mechanistic analysis of synthetic ramoplanin analogues as a guide to the design of improved antibiotics. J. Am. Chem. Soc. 126, 7462–7463 (2004).
  Article CAS PubMed Google Scholar
• Cudic, P. et al. Functional analysis of the lipoglycodepsipeptide antibiotic ramoplanin. Chem. Biol. 9, 897–906 (2002).
  Article CAS PubMed Google Scholar
• Watson, J. D. & Milner-White, E. J. A novel main-chain anion-binding site in proteins: The nest. A particular combination of phi, psi values in successive residues gives rise to anion-binding sites that occur commonly and are found often at functionally important regions. J. Mol. Biol. 315, 171–182 (2002).
  Article CAS PubMed Google Scholar
• Watson, J. D. & Milner-White, E. J. The conformations of polypeptide chains where the main-chain parts of successive residues are enantiomeric. Their occurrence in cation and anion-binding regions of proteins. J. Mol. Biol. 315, 183–1191 (2002).
  Article CAS PubMed Google Scholar
• Singh, M. P. et al. Mannopeptimycins, new cyclic glycopeptide antibiotics produced by Streptomyces hygroscopicus LL-AC98: antibacterial and mechanistic activities. Antimicrob. Agents Chemother. 47, 62–69 (2003).
  Article CAS PubMed PubMed Central Google Scholar
• He, H. et al. Mannopeptimycins, novel antibacterial glycopeptides from Streptomyces hygroscopicus, LL-AC98. J. Am. Chem. Soc. 124, 9729–9736 (2002).
  Article CAS PubMed Google Scholar
• Dushin, R. G. et al. Hydrophobic acetal and ketal derivatives of mannopeptimycin-a and desmethylhexa-hydromannopeptimycin-a: semisynthetic glycopeptides with potent activity against Gram-positive bacteria. J. Med. Chem. 47, 3487–3490 (2004).
  Article CAS PubMed Google Scholar
• Ruzin, A. et al. Mechanism of action of the mannopeptimycins, a novel class of glycopeptide antibiotics active against vancomycin-resistant Gram-positive bacteria. Antimicrob. Agents Chemother. 48, 728–738 (2004). The authors show that the mannopeptimycins target Lipid II.
  Article CAS PubMed PubMed Central Google Scholar
• Shoji, J. et al. Isolation and characterization of new peptide antibiotics, plusbacins A1-A4 and B1-B4. J. Antibiot. (Tokyo) 45, 817–823 (1992).
  Article CAS Google Scholar
• Shoji, J. et al. Isolation and characterization of katanosins A and B. J. Antibiot. (Tokyo) 41, 713–718 (1988).
  Article CAS Google Scholar
• Maki, H., Miura, K. & Yamano, Y. Katanosin B and plusbacin A3, inhibitors of peptidoglycan synthesis in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 45, 1823–1827 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Jarvis, B. Resistance to nisin and production of nisin-inactivating enzymes by several Bacillus species. J. Gen. Microbiol. 47, 33–48 (1967).
  Article CAS PubMed Google Scholar
• Jarvis, B. & Farr, J. Partial purification, specificity and mechanism of action of the nisin-inactivating enzyme from Bacillus cereus. Biochim. Biophys. Acta 227, 232–240 (1971).
  Article CAS PubMed Google Scholar
• Froseth, B. R. & McKay, L. L. Molecular characterization of the nisin resistance region of Lactococcus-lactis subsp lactis biovar diacetylactis Drc3. Appl. Environ. Microbiol. 57, 804–811 (1991).
  CAS PubMed PubMed Central Google Scholar
• Mantovani, H. C. & Russell, J. B. Nisin resistance of Streptococcus bovis. Appl. Environ. Microbiol. 67, 808–813 (2001).
  Article CAS PubMed PubMed Central Google Scholar
• Breuer, B. & Radler, F. Inducible resistance against nisin in Lactobacillus casei. Arch. Microbiol. 165, 114–118 (1996).
  Article CAS Google Scholar
• Severina, E., Severin, A. & Tomasz, A. Antibacterial efficacy of nisin against multidrug-resistant Gram positive pathogens. J. Antimicrob. Chemother. 41, 341–347 (1998).
  Article CAS PubMed Google Scholar
• MaisnierPatin, S. & Richard, J. Cell wall changes in nisin-resistant variants of Listeria innocua grown in the presence of high nisin concentrations. FEMS Microbiol. Lett. 140, 29–35 (1996).
  Article CAS Google Scholar
• Verheul, A., Russell, N. J., van't Hof, R., Rombouts, F. M. & Abee, T. Modifications of membrane phospholipid composition in nisin-resistant Listeria monocytogenes Scott A. Appl. Environ. Microbiol. 63, 3451–3457 (1997).
  CAS PubMed PubMed Central Google Scholar
• Crandall, A. D. & Montville, T. J. Nisin resistance in Listeria monocytogenes ATCC 700302 is a complex phenotype. Appl. Environ. Microbiol. 64, 231–237 (1998).
  CAS PubMed PubMed Central Google Scholar
• Davies, E. A., Falahee, M. B. & Adams, M. R. Involvement of the cell envelope of Listeria monocytogenes in the acquisition of nisin resistance. J. Appl. Bacteriol. 81, 139–146 (1996).
  Article CAS PubMed Google Scholar
• Neuhaus, F. C. & Baddiley, J. A continuum of anionic charge: structures and functions of D-Alanyl-Teichoic acids in Gram-positive bacteria. Microb. Mol. Biol. Rev. 67, 686–723 (2003).
  Article CAS Google Scholar
• Kramer, N. E. Nisin resistance in Gram-positive bacteria. Ph.D. Thesis, Utrecht Univ. (2005).
• Cao, M. & Helmann, J. D. The Bacillus subtilis extracytoplasmic-function sigma(X) factor regulates modification of the cell envelope and resistance to cationic antimicrobial peptides. J. Bacteriol. 186, 1136–1146 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• Farver, D. K., Hedge, D. D. & Lee, S. C. Ramoplanin: a lipoglycodepsipeptide antibiotic. Ann. Pharmacother. 39, 863–868 (2005).
  Article CAS PubMed Google Scholar
• Brumfitt, W., Salton, M. R. J. & Hamilton-Miller, J. M. T. Nisin, alone and combined with peptidoglycan-modulating antibiotics: activity against methicillin-resistant Staphylococcus aureus and vancomycin-resistant enterococci. J. Antimicrob. Chemother. 50, 731–734 (2002).
  Article CAS PubMed Google Scholar
• Bavin, E. M., Beach, A. S., Falconer, R. & Friedman, R. Nisin in experimental tuberculosis. The Lancet 259, 127–129 (1952).
  Article Google Scholar
• Mota-Meira, M., LaPointe, G., Lacroix, C. & Lavoie, M. C. MICs of mutacin B-Ny266, nisin A, vancomycin, and oxacillin against bacterial pathogens. Antimicrob. Agents Chemother. 44, 24–29 (2000).
  Article CAS PubMed PubMed Central Google Scholar
• Peschel, A. et al. Inactivation of the dlt operon in Staphylococcus aureus confers sensitivity to defensins, protegrins, and other antimicrobial peptides. J. Biol. Chem. 274, 8405–8410 (1999). Describes how the incorporation of positively charged residues ( D -Ala) in the cell wall affects resistance to peptide antibiotics.
  Article CAS PubMed Google Scholar
• Stevens, K. A., Sheldon, B. W., Klapes, N. A. & Klaenhammer, T. R. Nisin treatment for inactivation of Salmonella species and other Gram-negative bacteria. Appl. Environ. Microbiol. 57, 3613–3615 (1991).
  CAS PubMed PubMed Central Google Scholar
• Yuan, J., Zhang, Z. Z., Chen, X. Z., Yang, W. & Huan, L. D. Site-directed mutagenesis of the hinge region of nisinZ and properties of nisinZ mutants. Appl. Microbiol. Biotechnol. 64, 806–815 (2004).
  Article CAS PubMed Google Scholar
• He, H. Mannopeptimycins, a novel class of glycopeptide antibiotics active against Gram-positive bacteria. Appl. Microbiol. Biotechnol. 67, 444–452 (2005).
  Article CAS PubMed Google Scholar
• Goldstein, B. P., Wei, J., Greenberg, K. & Novick, R. Activity of nisin against Streptococcus pneumoniae, in vitro, a mouse infection model. J. Antimicrob. Chemother. 42, 277–278 (1998).
  Article CAS PubMed Google Scholar
• Kordel, M. & Sahl, H. G. Susceptibility of bacterial, eukaryotic and artificial membranes to the disruptive action of the cationic peptides Pep 5 and nisin. FEMS Microbiol. Lett. 34, 139–144 (1986).
  Article CAS Google Scholar
• Chatterjee, S. et al. Mersacidin, a new antibiotic from Bacillus. In vitro and in vivo antibacterial activity. J. Antibiot. (Tokyo) 45, 839–845 (1992).
  Article CAS Google Scholar
• Kruszewska, D. et al. Mersacidin eradicates methicillin-resistant Staphylococcus aureus (MRSA) in a mouse rhinitis model. J. Antimicrob. Chemother. 54, 648–653 (2004).
  Article CAS PubMed Google Scholar
• Weiss, W. J., Murphy, T., Lenoy, E. & Young, M. In vivo efficacy and pharmacokinetics of AC98–6446, a novel cyclic glycopeptide, in experimental infection models. Antimicrob. Agents Chemother. 48, 1708–1712 (2004).
  Article CAS PubMed PubMed Central Google Scholar
• McCormick, M. H., McGuire, J. M., Pittenger, G. E., Pittenger, R. C. & Stark, W. M. Vancomycin, a new antibiotic. I. Chemical and biologic properties. Antibiot. Annu. 3, 606–611 (1956).
  CAS Google Scholar
• Williamson, M. P. & Williams, D. H. Structure revision of the antibiotic vancomycin. Use of nuclear Overhauser effect difference spectroscopy. J. Am. Chem. Soc. 103, 6580–6585 (1981).
  Article CAS Google Scholar
• Sheldrick, G. M., Jones, P. G., Kennard, O., Williams, D. H. & Smith, G. A. Structure of vancomycin and its complex with acetyl-D-alanyl-D-alanine. Nature 271, 223–225 (1978). Describes elucidation of the binding interactions formed between vancomycin and Lipid II.
  Article CAS PubMed Google Scholar
• Harris, C. M. & Harris, T. M. Structure of the glycopeptide antibiotic vancomycin. Evidence for an asparagine residue in the peptide. J. Am. Chem. Soc. 104, 4293–4295 (1982).
  Article CAS Google Scholar
• Anderson, J. S., Matsuhashi, M., Haskin, M. A. & Strominger, J. L. Lipid-phosphoacetylmuramyl-pentapeptide and lipid-phosphodisaccharide-pentapeptide: presumed membrane transport intermediates in cell wall synthesis. Proc. Natl Acad. Sci. USA 53, 881–889 (1965).
  Article CAS PubMed Google Scholar
• Perkins, H. R. Specificity of combination between mucopeptide precursors and vancomycin or ristocetin. Biochem. J. 111, 195–205 (1969).
  Article CAS PubMed PubMed Central Google Scholar
• Chatterjee, A. N. & Perkins, H. R. Compounds formed between nucleotides related to the biosynthesis of bacterial cell wall and vancomycin. Biochem. Biophys. Res. Commun. 24, 489–494 (1966).
  Article CAS PubMed Google Scholar
• Bordet, C. & Perkins, H. R. Iodinated vancomycin and mucopeptide biosynthesis by cell-free preparations from Micrococcus lysodeikticus. Biochem. J. 119, 877–883 (1970).
  Article CAS PubMed PubMed Central Google Scholar
• Molinari, H., Pastore, A., Lian, L. Y., Hawkes, G. E. & Sales, K. Structure of vancomycin and a vancomycin/D-Ala-D-Ala complex in solution. Biochemistry 29, 2271–2277 (1990).
  Article CAS PubMed Google Scholar
• Vollmerhaus, P. J., Breukink, E. & Heck, A. J. Getting closer to the real bacterial cell wall target: biomolecular interactions of water-soluble lipid II with glycopeptide antibiotics. Chemistry 9, 1556–1565 (2003).
  Article CAS PubMed Google Scholar
• Malabarba, A. & Goldstein, B. P. Origin, structure, and activity in vitro and in vivo of dalbavancin. J. Antimicrob. Chemother. 55 (Suppl. 2), ii15–20 (2005).
  Article CAS PubMed Google Scholar
• Higgins, D. L. et al. Telavancin, a multifunctional lipoglycopeptide, disrupts both cell wall synthesis and cell membrane integrity in methicillin-resistant Staphylococcus aureus. Antimicrob. Agents Chemother. 49, 1127–1134 (2005).
  Article CAS PubMed PubMed Central Google Scholar
• Mercier, R. C. & Hrebickova, L. Oritavancin: a new avenue for resistant Gram-positive bacteria. Expert Rev. Anti Infect. Ther. 3, 325–332 (2005).
  Article CAS PubMed Google Scholar
• Barrett, M. S., Wenzel, R. P. & Jones, R. N. In vitro activity of mersacidin (M87-1551), an investigational peptide antibiotic tested against gram-positive bloodstream isolates. Diagn. Microbiol. Infect. Dis. 15, 641–644 (1992).
  Article CAS PubMed Google Scholar
• Petersen, P. J., Wang, T. Z., Dushin, R. G. & Bradford, P. A. Comparative in vitro activities of AC98–6446, a novel semisynthetic glycopeptide derivative of the natural product mannopeptimycin alpha, and other antimicrobial agents against Gram-positive clinical isolates. Antimicrob. Agents Chemother. 48, 739–746 (2004).
  Article CAS PubMed PubMed Central Google Scholar